Affiliation:
1. Department of Medicine II, University of Freiburg, D-79106 Freiburg, Germany
Abstract
Owing to the major limitations of current antiviral therapies in HBV (hepatitis B virus) infection, there is a strong need for novel therapeutic approaches to this major health burden. Stimulation of the host's innate and adaptive immune responses in a way that results in the resolution of viral infection is a promising approach. A better understanding of the virus–host interaction in acute and chronic HBV infection revealed several possible novel targets for antiviral immunotherapy. In the present review, we will discuss the current state of the art in HBV immunology and illustrate how control of infection could be achieved by immunotherapeutic interventions.
Reference94 articles.
1. EASL clinical practice guidelines: management of chronic hepatitis B;European Association for the Study of the Liver;J. Hepatol.,2009
2. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor;Ilan;Gastroenterology,1993
3. The molecular basis of the failed immune response in chronic HBV: therapeutic implications;Maini;J. Hepatol.,2010
4. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection;Bertoletti;Gut,2011
5. Pathogen recognition and innate immunity;Akira;Cell,2006
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献